La maladie de Parkinson au Canada (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Insulin‐like growth factor‐1‐dependent maintenance of neuronal metabolism through the phosphatidylinositol 3‐kinase–Akt pathway is inhibited by C2‐ceramide in CAD cells

Identifieur interne : 002575 ( Main/Exploration ); précédent : 002574; suivant : 002576

Insulin‐like growth factor‐1‐dependent maintenance of neuronal metabolism through the phosphatidylinositol 3‐kinase–Akt pathway is inhibited by C2‐ceramide in CAD cells

Auteurs : Gonzalo Arboleda [Royaume-Uni, Colombie] ; Tze-Jen Huang [Royaume-Uni] ; Catherine Waters [Royaume-Uni] ; Alex Verkhratsky [Royaume-Uni] ; Paul Fernyhough [Royaume-Uni, Canada] ; Rosemary M. Gibson [Royaume-Uni]

Source :

RBID : ISTEX:62EC02BE61195C4899FF6E3497EFAFF8BAC6820E

English descriptors

Abstract

Ceramide is a lipid second‐messenger generated in response to stimuli associated with neurodegeneration that induces apoptosis, a mechanism underlying neuronal death in Parkinson's disease. We tested the hypothesis that insulin‐like growth factor‐1 (IGF‐1) could mediate a metabolic response in CAD cells, a dopaminergic cell line of mesencephalic origin that differentiate into a neuronal‐like phenotype upon serum removal, extend processes resembling neurites, synthesize abundant dopamine and noradrenaline and express the catecholaminergic biosynthetic enzymes tyrosine hydroxylase and dopamine β‐hydroxylase, and that this process was phosphatidylinositol 3‐kinase (PI 3‐K)–Akt‐dependent and could be inhibited by C2‐ceramide. The metabolic response was evaluated as real‐time changes in extracellular acidification rate (ECAR) using microphysiometry. The IGF‐1‐induced ECAR response was associated with increased glycolysis, determined by increased NAD(P)H reduction, elevated hexokinase activity and Akt phosphorylation. C2‐ceramide inhibited all these changes in a dose‐dependent manner, and was specific, as it was not induced by the inactive C2‐ceramide analogue C2‐dihydroceramide. Inhibition of the upstream kinase, PI 3‐K, also inhibited Akt phosphorylation and the metabolic response to IGF‐1, similar to C2‐ceramide. Decreased mitochondrial membrane potential occurred after loss of Akt phosphorylation. These results show that IGF‐1 can rapidly modulate neuronal metabolism through PI 3‐K–Akt and that early metabolic inhibition induced by C2‐ceramide involves blockade of the PI 3‐K–Akt pathway, and may compromise the first step of glycolysis. This may represent a new early event in the C2‐ceramide‐induced cell death pathway that could coordinate subsequent changes in mitochondria and commitment of neurons to apoptosis.

Url:
DOI: 10.1111/j.1460-9568.2007.05557.x


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Insulin‐like growth factor‐1‐dependent maintenance of neuronal metabolism through the phosphatidylinositol 3‐kinase–Akt pathway is inhibited by C2‐ceramide in CAD cells</title>
<author>
<name sortKey="Arboleda, Gonzalo" sort="Arboleda, Gonzalo" uniqKey="Arboleda G" first="Gonzalo" last="Arboleda">Gonzalo Arboleda</name>
</author>
<author>
<name sortKey="Huang, Tze En" sort="Huang, Tze En" uniqKey="Huang T" first="Tze-Jen" last="Huang">Tze-Jen Huang</name>
</author>
<author>
<name sortKey="Waters, Catherine" sort="Waters, Catherine" uniqKey="Waters C" first="Catherine" last="Waters">Catherine Waters</name>
</author>
<author>
<name sortKey="Verkhratsky, Alex" sort="Verkhratsky, Alex" uniqKey="Verkhratsky A" first="Alex" last="Verkhratsky">Alex Verkhratsky</name>
</author>
<author>
<name sortKey="Fernyhough, Paul" sort="Fernyhough, Paul" uniqKey="Fernyhough P" first="Paul" last="Fernyhough">Paul Fernyhough</name>
</author>
<author>
<name sortKey="Gibson, Rosemary M" sort="Gibson, Rosemary M" uniqKey="Gibson R" first="Rosemary M." last="Gibson">Rosemary M. Gibson</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:62EC02BE61195C4899FF6E3497EFAFF8BAC6820E</idno>
<date when="2007" year="2007">2007</date>
<idno type="doi">10.1111/j.1460-9568.2007.05557.x</idno>
<idno type="url">https://api-v5.istex.fr/document/62EC02BE61195C4899FF6E3497EFAFF8BAC6820E/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002904</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002904</idno>
<idno type="wicri:Area/Istex/Curation">002904</idno>
<idno type="wicri:Area/Istex/Checkpoint">000A55</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000A55</idno>
<idno type="wicri:doubleKey">0953-816X:2007:Arboleda G:insulin:like:growth</idno>
<idno type="wicri:Area/Main/Merge">002818</idno>
<idno type="wicri:Area/Main/Curation">002575</idno>
<idno type="wicri:Area/Main/Exploration">002575</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Insulin‐like growth factor‐1‐dependent maintenance of neuronal metabolism through the phosphatidylinositol 3‐kinase–Akt pathway is inhibited by C2‐ceramide in CAD cells</title>
<author>
<name sortKey="Arboleda, Gonzalo" sort="Arboleda, Gonzalo" uniqKey="Arboleda G" first="Gonzalo" last="Arboleda">Gonzalo Arboleda</name>
<affiliation wicri:level="4">
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Faculty of Life Sciences, University of Manchester, Oxford Road, Manchester</wicri:regionArea>
<placeName>
<settlement type="city">Manchester</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Manchester</region>
<settlement type="city">Manchester</settlement>
</placeName>
<orgName type="university">Université de Manchester</orgName>
</affiliation>
<affiliation wicri:level="1">
<country wicri:rule="url">Colombie</country>
</affiliation>
</author>
<author>
<name sortKey="Huang, Tze En" sort="Huang, Tze En" uniqKey="Huang T" first="Tze-Jen" last="Huang">Tze-Jen Huang</name>
<affiliation wicri:level="4">
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Faculty of Life Sciences, University of Manchester, Oxford Road, Manchester</wicri:regionArea>
<placeName>
<settlement type="city">Manchester</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Manchester</region>
<settlement type="city">Manchester</settlement>
</placeName>
<orgName type="university">Université de Manchester</orgName>
</affiliation>
</author>
<author>
<name sortKey="Waters, Catherine" sort="Waters, Catherine" uniqKey="Waters C" first="Catherine" last="Waters">Catherine Waters</name>
<affiliation wicri:level="4">
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Faculty of Life Sciences, University of Manchester, Oxford Road, Manchester</wicri:regionArea>
<placeName>
<settlement type="city">Manchester</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Manchester</region>
<settlement type="city">Manchester</settlement>
</placeName>
<orgName type="university">Université de Manchester</orgName>
</affiliation>
</author>
<author>
<name sortKey="Verkhratsky, Alex" sort="Verkhratsky, Alex" uniqKey="Verkhratsky A" first="Alex" last="Verkhratsky">Alex Verkhratsky</name>
<affiliation wicri:level="4">
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Faculty of Life Sciences, University of Manchester, Oxford Road, Manchester</wicri:regionArea>
<placeName>
<settlement type="city">Manchester</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Manchester</region>
<settlement type="city">Manchester</settlement>
</placeName>
<orgName type="university">Université de Manchester</orgName>
</affiliation>
</author>
<author>
<name sortKey="Fernyhough, Paul" sort="Fernyhough, Paul" uniqKey="Fernyhough P" first="Paul" last="Fernyhough">Paul Fernyhough</name>
<affiliation wicri:level="4">
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Faculty of Life Sciences, University of Manchester, Oxford Road, Manchester</wicri:regionArea>
<placeName>
<settlement type="city">Manchester</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Manchester</region>
<settlement type="city">Manchester</settlement>
</placeName>
<orgName type="university">Université de Manchester</orgName>
</affiliation>
<affiliation wicri:level="4">
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Division of Neurodegenerative Disorders, St Boniface Hospital Research Centre and Department. of Pharmacology & Therapeutics, University of Manitoba, Winnipeg</wicri:regionArea>
<orgName type="university">Université du Manitoba</orgName>
<placeName>
<settlement type="city">Winnipeg</settlement>
<region type="state">Manitoba</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Gibson, Rosemary M" sort="Gibson, Rosemary M" uniqKey="Gibson R" first="Rosemary M." last="Gibson">Rosemary M. Gibson</name>
<affiliation wicri:level="4">
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Faculty of Life Sciences, University of Manchester, Oxford Road, Manchester</wicri:regionArea>
<placeName>
<settlement type="city">Manchester</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Manchester</region>
<settlement type="city">Manchester</settlement>
</placeName>
<orgName type="university">Université de Manchester</orgName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">European Journal of Neuroscience</title>
<idno type="ISSN">0953-816X</idno>
<idno type="eISSN">1460-9568</idno>
<imprint>
<publisher>Blackwell Publishing Ltd</publisher>
<pubPlace>Oxford, UK</pubPlace>
<date type="published" when="2007-05">2007-05</date>
<biblScope unit="volume">25</biblScope>
<biblScope unit="issue">10</biblScope>
<biblScope unit="page" from="3030">3030</biblScope>
<biblScope unit="page" to="3038">3038</biblScope>
</imprint>
<idno type="ISSN">0953-816X</idno>
</series>
<idno type="istex">62EC02BE61195C4899FF6E3497EFAFF8BAC6820E</idno>
<idno type="DOI">10.1111/j.1460-9568.2007.05557.x</idno>
<idno type="ArticleID">EJN5557</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0953-816X</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>apoptosis</term>
<term>glycolysis</term>
<term>hexokinase</term>
<term>mitochondria</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Ceramide is a lipid second‐messenger generated in response to stimuli associated with neurodegeneration that induces apoptosis, a mechanism underlying neuronal death in Parkinson's disease. We tested the hypothesis that insulin‐like growth factor‐1 (IGF‐1) could mediate a metabolic response in CAD cells, a dopaminergic cell line of mesencephalic origin that differentiate into a neuronal‐like phenotype upon serum removal, extend processes resembling neurites, synthesize abundant dopamine and noradrenaline and express the catecholaminergic biosynthetic enzymes tyrosine hydroxylase and dopamine β‐hydroxylase, and that this process was phosphatidylinositol 3‐kinase (PI 3‐K)–Akt‐dependent and could be inhibited by C2‐ceramide. The metabolic response was evaluated as real‐time changes in extracellular acidification rate (ECAR) using microphysiometry. The IGF‐1‐induced ECAR response was associated with increased glycolysis, determined by increased NAD(P)H reduction, elevated hexokinase activity and Akt phosphorylation. C2‐ceramide inhibited all these changes in a dose‐dependent manner, and was specific, as it was not induced by the inactive C2‐ceramide analogue C2‐dihydroceramide. Inhibition of the upstream kinase, PI 3‐K, also inhibited Akt phosphorylation and the metabolic response to IGF‐1, similar to C2‐ceramide. Decreased mitochondrial membrane potential occurred after loss of Akt phosphorylation. These results show that IGF‐1 can rapidly modulate neuronal metabolism through PI 3‐K–Akt and that early metabolic inhibition induced by C2‐ceramide involves blockade of the PI 3‐K–Akt pathway, and may compromise the first step of glycolysis. This may represent a new early event in the C2‐ceramide‐induced cell death pathway that could coordinate subsequent changes in mitochondria and commitment of neurons to apoptosis.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Canada</li>
<li>Colombie</li>
<li>Royaume-Uni</li>
</country>
<region>
<li>Angleterre</li>
<li>Grand Manchester</li>
<li>Manitoba</li>
</region>
<settlement>
<li>Manchester</li>
<li>Winnipeg</li>
</settlement>
<orgName>
<li>Université de Manchester</li>
<li>Université du Manitoba</li>
</orgName>
</list>
<tree>
<country name="Royaume-Uni">
<region name="Angleterre">
<name sortKey="Arboleda, Gonzalo" sort="Arboleda, Gonzalo" uniqKey="Arboleda G" first="Gonzalo" last="Arboleda">Gonzalo Arboleda</name>
</region>
<name sortKey="Fernyhough, Paul" sort="Fernyhough, Paul" uniqKey="Fernyhough P" first="Paul" last="Fernyhough">Paul Fernyhough</name>
<name sortKey="Gibson, Rosemary M" sort="Gibson, Rosemary M" uniqKey="Gibson R" first="Rosemary M." last="Gibson">Rosemary M. Gibson</name>
<name sortKey="Huang, Tze En" sort="Huang, Tze En" uniqKey="Huang T" first="Tze-Jen" last="Huang">Tze-Jen Huang</name>
<name sortKey="Verkhratsky, Alex" sort="Verkhratsky, Alex" uniqKey="Verkhratsky A" first="Alex" last="Verkhratsky">Alex Verkhratsky</name>
<name sortKey="Waters, Catherine" sort="Waters, Catherine" uniqKey="Waters C" first="Catherine" last="Waters">Catherine Waters</name>
</country>
<country name="Colombie">
<noRegion>
<name sortKey="Arboleda, Gonzalo" sort="Arboleda, Gonzalo" uniqKey="Arboleda G" first="Gonzalo" last="Arboleda">Gonzalo Arboleda</name>
</noRegion>
</country>
<country name="Canada">
<region name="Manitoba">
<name sortKey="Fernyhough, Paul" sort="Fernyhough, Paul" uniqKey="Fernyhough P" first="Paul" last="Fernyhough">Paul Fernyhough</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002575 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002575 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:62EC02BE61195C4899FF6E3497EFAFF8BAC6820E
   |texte=   Insulin‐like growth factor‐1‐dependent maintenance of neuronal metabolism through the phosphatidylinositol 3‐kinase–Akt pathway is inhibited by C2‐ceramide in CAD cells
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022